ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
Press Releases
ThinkCyte Inc.  
January 27, 2025

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

TOKYO, Jan. 27, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of

avatar profile Olean Times Herald

Olean Times Herald


Local & Social